Citigroup Has Lowered Expectations for Krystal Biotech (NASDAQ:KRYS) Stock Price
Krystal Biotech (NASDAQ:KRYS – Free Report) had its target price decreased by Citigroup from $215.00 to $155.00 in a research note published on Friday morning,Benzinga reports. Citigroup currently has a neutral rating on the stock. A number of other brokerages have also recently issued reports on KRYS. HC Wainwright reissued a “buy” rating and issued […]
Krystal Biotech (NASDAQ:KRYS – Free Report) had its target price decreased by Citigroup from $215.00 to $155.00 in a research note published on Friday morning,Benzinga reports. Citigroup currently has a neutral rating on the stock. A number of other brokerages have also recently issued reports on KRYS. HC Wainwright reissued a “buy” rating and issued […]
